Alzheimer’s super-cleaner brain cells & AI model for whole genomes - News (Mar 6, 2026)

We’ll start with that Alzheimer’s headline, because it’s the kind of idea that makes researchers lean forward. A team at Washington University School of Medicine reported they engineered astrocytes—support cells in the brain—to act like targeted “super cleaners.” The twist is borrowed from cancer medicine: they used a harmless virus to deliver a gene that helps these cells recognize amyloid beta, the protein that builds up into Alzheimer’s-linked plaques. In mice that were destined to develop plaques, one injection given early kept them plaque-free for months. And in older mice that already had heavy plaque buildup, the same one-time treatment cut plaque levels by about half. It’s early-stage and still a long road to human testing, but the appeal is obvious: today’s anti-amyloid antibody therapies can mean repeated infusions, while a durable, single intervention—if it proves safe—could change the burden on patients and families.

Staying in medical research, there’s another story pointing to more personalized treatment—this time in cancer. In the U.K., an NHS-backed trial is testing personalized cancer vaccines designed to reduce the odds of the disease returning, with one participant describing it as a chance to help push the science forward after being treated for advanced head and neck cancer. The key idea is tailoring an mRNA-based vaccine to the individual tumor, alongside immunotherapy, to help the immune system spot lingering cancer cells. It’s not a guarantee and it’s not a standard-of-care yet—but it reflects a broader shift: oncology is moving from one-size-fits-all regimens toward therapies tuned to the patient’s specific cancer signature.

Another health development is raising eyebrows for a different reason: diabetes drugs that may be doing more than managing blood sugar and weight. A large observational analysis using U.S. Veterans Affairs health records—over 600,000 people with Type 2 diabetes—found that patients prescribed GLP-1 medications were linked to markedly better addiction-related outcomes. Among people who already had substance use disorders, GLP-1 use was associated with fewer overdoses, fewer substance-related deaths, and fewer suicide attempts over a multi-year period. And among people without prior substance use disorders, GLP-1 users showed a lower likelihood of developing problems with alcohol, opioids, cocaine, or nicotine. Important caveat: this isn’t proof of cause and effect. But it adds weight to the idea that these drugs may dampen cravings by acting on brain reward circuits—an intriguing possibility in a field where treatment options are still far too limited.

Now to the intersection of biology and AI: researchers are out with a new “genome language model” called Evo 2, trained across a wide span of life—bacteria, archaea, eukaryotes, and even phages—using a newly curated dataset. The significance isn’t the hype around bigger models; it’s what long context means for biology. Evo 2 is designed to read extremely long stretches of DNA in one go, which matters because many important genetic signals are spread out—especially in complex organisms. The team says the model can help score how damaging certain genetic changes might be, flag gene features, and even generate long DNA sequences in silico. They also deliberately limited some viral data for safety reasons, a reminder that powerful bio-AI comes with governance questions, not just scientific opportunity.

Let’s widen the lens to geopolitics, starting with what the U.N. is warning could become the next big choke point: critical minerals. At the Security Council, the U.N.’s political chief said demand for minerals used in everything from phones to missiles could triple by 2030 and quadruple by 2040. She also pointed to how enormous this market already is—trade in raw and semi-processed minerals reaching into the trillions of dollars. Why it matters: these materials sit at the crossroads of the energy transition and national security. The meeting underscored a reality governments are increasingly saying out loud—supply chains for lithium, cobalt, nickel, and rare earths are now strategic terrain, not just commerce. And that raises pressure for “responsible mining” that doesn’t bankroll conflict or corruption, especially in resource-rich regions already under strain.

Europe’s security rethink is also showing up in Finland, where the government is proposing to end a decades-old legal ban that prevents nuclear weapons from being brought onto Finnish territory. Officials argue the security environment has fundamentally changed since Russia’s full-scale invasion of Ukraine, and that Finland’s posture should align more closely with NATO’s deterrence framework. This is not Finland announcing it wants nuclear weapons of its own. It’s about legal flexibility—making room for NATO-linked defense arrangements that would have been politically unthinkable just a few years ago. With Finland sharing NATO’s longest border with Russia, the proposal is a vivid example of how the war in Ukraine continues to rewire policies across the region.

Energy security is another area where geopolitics is translating into real-time planning. Japanese media report Russia is preparing to redirect part of its crude oil exports toward India amid fears that a U.S.-Israel strike on Iran could disrupt global supplies. A tanker carrying millions of barrels of Russian crude is said to be moving near Indian waters, potentially arriving within weeks. What makes this story tense is India’s vulnerability to disruption: limited domestic stockpiles and heavy exposure to oil flows that pass through the Strait of Hormuz. Russia is signaling it could cover a large share of India’s needs if a prolonged crisis hits—but ultimately, the decision would hinge on India’s government, balancing energy needs against sanctions pressure and shifting relationships with Washington and Beijing.

On the business and tech front, Broadcom delivered a major moment for the AI infrastructure story. The company beat expectations, issued upbeat guidance, and its CEO said he expects next year’s AI chip revenue to be well above one hundred billion dollars. That number is striking not just for its scale, but for what it implies: the AI boom is maturing into a phase where big players increasingly want custom chips designed for their specific workloads, not just off-the-shelf accelerators. Broadcom is positioning itself as the behind-the-scenes builder for that shift, and investors clearly liked what they heard.

But the global AI chip market may also be heading for more friction. Bloomberg reports the Trump administration is weighing draft rules that would require U.S. government approval for shipments of advanced AI chips to essentially any destination outside the United States. If that happens, it would expand oversight dramatically, slowing deals and adding uncertainty for buyers and sellers alike. The strategic gamble is familiar: tighter controls can limit sensitive technology from reaching rivals, but they can also push customers to alternative suppliers over time. And with competition improving outside the U.S., the question is how much influence Washington gains—or gives away—by putting more of the world’s chip orders behind a government review desk.

Finally, a quick look at transport innovation—tempered by reality. In China, startup AutoFlight showcased a large electric vertical takeoff and landing aircraft prototype, designed to carry up to ten passengers. The demo flight was short, controlled, and clearly staged—but it signals where China’s “low-altitude economy” ambitions are aiming: beyond delivery drones and toward passenger-scale aircraft. The interesting part isn’t that flying taxis are arriving tomorrow—they’re not. The hurdles are still big: certification, safety standards, air traffic coordination, and the ground infrastructure to support routine operations. Still, building bigger prototypes suggests the industry is testing what “mass transit in the sky” could eventually look like, if regulators and cities decide it’s worth the complexity.